Arcutis Canada's Zoryve cream wins Health Canada approval for children 2 to 5
Arcutis Canada says Zoryve cream 0.05% receives Health Canada approval for children aged 2 to 5 years with mild to moderate atopic dermatitis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.